Nygard Biotec
Nygard Biotec

The Movie

Peter Nygards 4 Step Strategy:

Step 1: Obtaining the right technology

University of Oregon Scientist, Dr. Shoukhrat Mitalipov explains, “It’s been 15 years since we invented the embryonic stem cell, and no one has been able to figure out how to use it.”   The procedure inserts adult human DNA into an unfertilised human egg, so that the growing stem cells can be used to treat serious disease and ageing.

 

“The way in which these stem cell lines were derived is from embryos that were created in the process of In Vitro Fertlisation (IVF), and, in fact, there are hundreds of thousands of these embryos that are simply being discarded,” said Dr. Francis Collins, Director of the US National Institute of health.

Step 2: Finding the perfect setting

After lengthy international travels, Mr. Nygard settled in the Bahamas for good reason many years ago.  Recognised by its popularity among A-class celebrities and the rich and famous, the Bahamas is a celebrated holiday destination with beautiful weather, a welcoming economy and an ever-friendly culture.  He believes that his new home would be perfect for both his business and the Bahamian people.

Step 3: Educating the law-makers

Mr Nygard needed the Bahamian government to willingly adopt supportive legislation for his stem cell studies.  This was a critical step in the progression of his extensive plans for research. He says that Bahama’s current Prime Minister Perry Christie "showed tremendous courage and political savviness to guide this through the legislature”.

 

PM Christie states in the video above that:“Two years ago Peter Nygård called me to say that if your country is prepared to pass legislation, I will find a way to bring scientists who I have retained. I am prepared to have them come into the Bahamas.”

 

The stem cell bill was passed in January of 2014 and was the first time the Bahamas’ ‘Medical Act’ had been revised in over 12 years. 

Step 4: Planing and construction of the scientific facilities

The construction of a multi-million dollar facility which develops both genomic sequencing and embryonic stem-cell technology would be the first of its kind anywhere in the world. 

 

While importing the most advanced stem cell technologies available, the aim is to also expand research into commercial genome sequencing (GS). This is described as the mapping of an organism’s entire DNA sequence, potentially used to predict one’s risk of developing a range of genetically inherited pathologies. 

Stem Cell News: Science Daily

Mini kidneys grown from stem cells give new insights into kidney disease and therapies (Tue, 20 Aug 2019)
>> Read more

Scientists reverse aging process in rat brain stem cells (Wed, 14 Aug 2019)
>> Read more

Bacteria made to mimic cells, form communities (Mon, 12 Aug 2019)
>> Read more

Novel dual stem cell therapy improving cardiac regeneration (Fri, 09 Aug 2019)
>> Read more

A new method of tooth repair? Scientists uncover mechanisms to inform future treatment (Fri, 09 Aug 2019)
>> Read more

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes (Thu, 08 Aug 2019)
>> Read more

Study links progenitor cells to age-related prostate growth (Tue, 06 Aug 2019)
>> Read more

Researchers make immunotherapy work for treatment-resistant lymphoma (Mon, 05 Aug 2019)
>> Read more

Old cells, new tricks: important clue to AML diagnosis and treatment discovered (Thu, 01 Aug 2019)
>> Read more

Assessing direct-to-consumer stem cell clinics (Thu, 01 Aug 2019)
>> Read more

Uncovering secrets of bone marrow cells and how they differentiate (Wed, 31 Jul 2019)
>> Read more

Targeting a blood stem cell subset shows lasting, therapeutically relevant gene editing (Wed, 31 Jul 2019)
>> Read more

Skin in balance: Joint forces of polarity and cell mechanics (Tue, 30 Jul 2019)
>> Read more

Stem cell research sheds new light on the skin (Tue, 30 Jul 2019)
>> Read more

Mechanical forces control cell fate during brain formation (Mon, 29 Jul 2019)
>> Read more

Print Print | Sitemap
© Nygard Biotech